Does APIXABAN Cause Pulmonary congestion? 78 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 78 reports of Pulmonary congestion have been filed in association with APIXABAN (ELIQUIS). This represents 0.1% of all adverse event reports for APIXABAN.
78
Reports of Pulmonary congestion with APIXABAN
0.1%
of all APIXABAN reports
18
Deaths
57
Hospitalizations
How Dangerous Is Pulmonary congestion From APIXABAN?
Of the 78 reports, 18 (23.1%) resulted in death, 57 (73.1%) required hospitalization, and 24 (30.8%) were considered life-threatening.
Is Pulmonary congestion Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for APIXABAN. However, 78 reports have been filed with the FAERS database.
What Other Side Effects Does APIXABAN Cause?
Death (18,501)
Cerebrovascular accident (7,237)
Atrial fibrillation (5,690)
Off label use (5,590)
Thrombosis (5,298)
Fall (5,063)
Cardiac disorder (4,917)
Haemorrhage (4,770)
Dyspnoea (4,379)
Gastrointestinal haemorrhage (4,030)
What Other Drugs Cause Pulmonary congestion?
ALBUTEROL (801)
ETANERCEPT (326)
METHOTREXATE (312)
PREDNISONE (309)
OMALIZUMAB (291)
RITUXIMAB (258)
MEPOLIZUMAB (254)
ABATACEPT (219)
SACUBITRIL\VALSARTAN (216)
MORPHINE (212)
Which APIXABAN Alternatives Have Lower Pulmonary congestion Risk?
APIXABAN vs APOMORPHINE
APIXABAN vs APRACLONIDINE
APIXABAN vs APREMILAST
APIXABAN vs APREPITANT
APIXABAN vs APROTININ